April 16, 2021
Via: medicaldevice-network.comAbiomed has enrolled the first patient in the PROTECT IV trial, which aims to obtain the clinical evidence needed to get a Class I guideline recommendation for Impella heart pumps in high-risk percutaneous coronary intervention (HRPCI). The first patient was […]